✦ LIBER ✦

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network

✍ Scribed by Raj Vuppalanchi; Robert J. Gould; Laura A. Wilson; Aynur Unalp-Arida; Oscar W. Cummings; Naga Chalasani; Kris V. Kowdley; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 194 KB
Volume: 6
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-011-9277-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Portal chronic inflammation in nonalcoho

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

✍ Elizabeth M. Brunt; David E. Kleiner; Laura A. Wilson; Aynur Unalp; Cynthia E. B 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

Quality of life in adults with nonalcoho

Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network

✍ Kristin David; Kris V. Kowdley; Aynur Unalp; Fasiha Kanwal; Elizabeth M. Brunt; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 1 views

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States. The association between NAFLD and quality of life (QOL) remains unclear. These data are important to estimate the burden of illness in NAFLD. The aim was to report QOL scores of adults with NAFLD

Atorvastatin decreases serum levels of a

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

✍ Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Is 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 202 KB

Impact of trough serum level on radiogra

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study

✍ Tsutomu Takeuchi; Nobuyuki Miyasaka; Kazuhiko Inoue; Tohru Abe; Takao Koike 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 307 KB

Increased fructose consumption is associ

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

✍ Manal F. Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption. Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls. Because fructose elicits metabolic pertur

Serum ferritin is an independent predict

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

✍ Kris V. Kowdley; Patricia Belt; Laura A. Wilson; Matthew M. Yeh; Brent A. Neusch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 2 views

Serum ferritin (SF) levels are commonly elevated in patients with nonalcoholic fatty liver disease (NAFLD) because of systemic inflammation, increased iron stores, or both. The aim of this study was to examine the relationship between elevated SF and NAFLD severity. Demographic, clinical, histologic